This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Abbott Molecular Inc.. Active years: 2020-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2022
Title: The Innovative Contributions of Rupinder Kular
Introduction
Rupinder Kular is a notable inventor based in Des Plaines, IL (US). She has made significant contributions to the field of cancer research through her innovative patents. With a total of 2 patents, Kular's work focuses on advancing the detection of molecular markers relevant to cancer.
Latest Patents
Kular's latest patents include technology related to the detection of epidermal growth factor receptor (EGFR) mRNA and EGFRvIII mRNA in biological samples. This technology is crucial for quantifying and detecting these molecular markers, which play a significant role in cancer diagnostics and treatment.
Career Highlights
Rupinder Kular is currently employed at Abbott Molecular Inc., where she continues to develop groundbreaking technologies in the medical field. Her work has the potential to improve cancer detection and treatment options for patients.
Collaborations
Kular collaborates with esteemed colleagues such as Jeffrey D Wuitschick and Kevin S Nelson, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Rupinder Kular's contributions to cancer research through her patents and work at Abbott Molecular Inc. highlight her role as a leading inventor in the field. Her innovative technologies are paving the way for advancements in cancer diagnostics and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile